These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 7512642)

  • 1. Deranged CD44 gene activity in malignancy.
    Tarin D; Matsumura Y
    J Pathol; 1993 Dec; 171(4):249-50. PubMed ID: 7512642
    [No Abstract]   [Full Text] [Related]  

  • 2. The variant mRNA isoform of human metastasis gene (CD44V) detected in the cell lines of human hepatocellular carcinoma.
    Harn HJ; Ho LI; Yu CP; Wang MW; Lee HS; Lin JJ; Lee WH; Isola NR; Cooper DL
    Biochem Mol Biol Int; 1994 Feb; 32(2):233-8. PubMed ID: 7517252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New CD44 splice variants associated with human breast cancers.
    Iida N; Bourguignon LY
    J Cell Physiol; 1995 Jan; 162(1):127-33. PubMed ID: 7529235
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of alternatively spliced CD44 mRNA in sheep renal allografts.
    Krishnan R; Kireta S; Carter JK; Grooby WL; Rao MM; Russ GR
    Transplant Proc; 1995 Jun; 27(3):2170-1. PubMed ID: 7540778
    [No Abstract]   [Full Text] [Related]  

  • 5. Abnormal retention of intron 9 in CD44 gene transcripts in human gastrointestinal tumors.
    Yoshida K; Bolodeoku J; Sugino T; Goodison S; Matsumura Y; Warren BF; Toge T; Tahara E; Tarin D
    Cancer Res; 1995 Oct; 55(19):4273-7. PubMed ID: 7545538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD44 isoform expression in primary and metastatic pancreatic adenocarcinoma.
    Rall CJ; Rustgi AK
    Cancer Res; 1995 May; 55(9):1831-5. PubMed ID: 7537174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of CD44 variant isoforms with hyaluronic acid and the cytoskeleton in human prostate cancer cells.
    Welsh CF; Zhu D; Bourguignon LY
    J Cell Physiol; 1995 Sep; 164(3):605-12. PubMed ID: 7544357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alternative splicing of CD44 pre-mRNA in human colorectal tumors.
    Finn L; Dougherty G; Finley G; Meisler A; Becich M; Cooper DL
    Biochem Biophys Res Commun; 1994 Apr; 200(2):1015-22. PubMed ID: 7513991
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of CD44 in normal human versus tumor endometrial tissues: possible implication of reduced expression of CD44 in lymph-vascular space involvement of cancer cells.
    Fujita N; Yaegashi N; Ide Y; Sato S; Nakamura M; Ishiwata I; Yajima A
    Cancer Res; 1994 Jul; 54(14):3922-8. PubMed ID: 7518345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splice variants of CD44 in human cervical cancer stage IB to IIB.
    Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
    Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of CD44 in prostate cancer cells: association with cell proliferation and invasive potential.
    Lokeshwar BL; Lokeshwar VB; Block NL
    Anticancer Res; 1995; 15(4):1191-8. PubMed ID: 7544562
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective expression of CD44 messenger RNA splice variants in four high grade human brain tumour cell lines.
    Harn HJ; Lee HS; Ho LI; Lee WH; Ding JH
    Biochem Mol Biol Int; 1994 Jul; 33(4):743-9. PubMed ID: 7526922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deranged activity of the CD44 gene and other loci as biomarkers for progression to metastatic malignancy.
    Tarin D; Matsumura Y
    J Cell Biochem Suppl; 1993; 17G():173-85. PubMed ID: 7516458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD44 isoforms during differentiation and development.
    Ruiz P; Schwärzler C; Günthert U
    Bioessays; 1995 Jan; 17(1):17-24. PubMed ID: 7535522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Normal human tissues, in addition to some tumors, express multiple different CD44 isoforms.
    Fox SB; Fawcett J; Jackson DG; Collins I; Gatter KC; Harris AL; Gearing A; Simmons DL
    Cancer Res; 1994 Aug; 54(16):4539-46. PubMed ID: 7519124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD44 isoforms in metastatic cancer.
    Ponta H; Sleeman J; Dall P; Moll J; Sherman L; Herrlich P
    Invasion Metastasis; 1994-1995; 14(1-6):82-6. PubMed ID: 7544777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of integrins and CD44 isoforms in non-Hodgkin's lymphomas: CD44 variant isoforms are preferentially expressed in high-grade malignant lymphomas.
    Terpe HJ; Koopmann R; Imhof BA; Günthert U
    J Pathol; 1994 Oct; 174(2):89-100. PubMed ID: 7525912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Occurrence of CD44 and its isoforms under orthological and pathological conditions].
    Terpe A; Franke F; Stark H; Gustmann C; Mackay C; Marston W; Günthert U
    Verh Dtsch Ges Pathol; 1993; 77():276-81. PubMed ID: 7511297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular aspects of invasion and metastasis of bladder cancer].
    Kagawa S
    Nihon Hinyokika Gakkai Zasshi; 1995 Jan; 86(1):82-3. PubMed ID: 7534842
    [No Abstract]   [Full Text] [Related]  

  • 20. Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteins.
    Parker D
    Lancet; 1995 Mar; 345(8949):583-4. PubMed ID: 7539877
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.